Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Protoporphyrin IX: Optimizing Photodynamic Compound Workflow
2026-04-28
Protoporphyrin IX stands at the crossroads of heme biosynthesis and photodynamic medicine. Discover how its unique properties enable advanced protocols in cancer diagnosis and ferroptosis modeling, with troubleshooting tips and experimental design insights for robust reproducibility.
-
Oligo (dT) 25 Beads: Practical Guide to mRNA Purification
2026-04-28
Oligo (dT) 25 Beads enable targeted, efficient isolation of intact eukaryotic mRNA by capturing polyA tails using superparamagnetic beads. This product is ideal for workflows requiring purified mRNA for RT-PCR, cDNA synthesis, or sequencing, but it is not suitable for non-polyadenylated RNA or applications needing total RNA fractions.
-
Clasto-Lactacystin β-lactone: Precision Proteasome Inhibitio
2026-04-27
Explore how Clasto-Lactacystin β-lactone, a potent proteasome inhibitor, uniquely advances research into viral immune evasion and necroptosis. This article connects molecular mechanism to assay design, highlighting translational impact for ubiquitin-proteasome pathway research.
-
PK/PD Evaluation of Cefazedone in Community-Acquired Pneumon
2026-04-27
This study rigorously investigates the pharmacokinetic and pharmacodynamic (PK/PD) profile of intravenous cefazedone sodium in adults with mild to moderate community-acquired pneumonia (CAP). By linking time-dependent drug exposure to clinical and microbiological outcomes, the research substantiates the rationality of a 2 g q12h dosing regimen, providing a scientific basis for optimized antibiotic therapy in CAP.
-
HyperScript III RT SuperMix: Precision in CRC Immunogenomics
2026-04-26
HyperScript III RT SuperMix delivers high-fidelity cDNA synthesis, enabling robust gene expression profiling even from challenging high-GC, low-abundance RNA. This workflow-critical tool streamlines reverse transcription for demanding colorectal cancer immunogenomics, with built-in genomic DNA removal for superior qPCR accuracy.
-
In Vitro Activity and Pharmacokinetics of Temafloxacin: Evid
2026-04-25
This study systematically evaluated the in vitro antibacterial activity, pharmacokinetics, and tissue penetration of temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, compared to other quinolones. The results highlight temafloxacin's potent efficacy against diverse Gram-positive and Gram-negative pathogens, robust tissue distribution, and pharmacokinetic profile supporting once or twice daily dosing regimens.
-
Ertapenem Sodium Salt: Precision Tools for Resistance Resear
2026-04-24
Ertapenem sodium salt enables robust, reproducible modeling of antibiotic resistance in Gram-positive and Gram-negative bacteria. This article translates recent epidemiological breakthroughs into practical assay workflows and troubleshooting strategies, empowering researchers to probe resistance mechanisms with confidence.
-
OM-MSCs Alleviate Golgi Stress via PEDF-PI3K/Akt/mTOR in Str
2026-04-24
This study reveals that olfactory mucosa mesenchymal stem cells (OM-MSCs) mitigate Golgi apparatus (GA) stress and excessive autophagy after cerebral ischemia/reperfusion injury by activating the PEDF-PI3K/Akt/mTOR signaling pathway. The findings highlight a mechanistic link between OM-MSCs, Golgi stress regulation, and neuroprotection, opening new avenues for targeted stroke therapy development.
-
Bifendate Inhibits Autophagy and Reduces Lipid Accumulation
2026-04-23
This study uncovers how bifendate (DDB) disrupts multiple steps of autophagy, particularly autophagosome-lysosome fusion and lysosome acidification, leading to attenuated oleic acid-induced lipid droplet accumulation in vitro. These mechanistic insights clarify DDB's hepatoprotective effects and offer new avenues for dissecting autophagy-lipid metabolism interplay in hepatic disease models.
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-04-23
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses challenges in SDS-PAGE and Western blot workflows by providing clear, tri-color molecular weight standards for protein size estimation and transfer verification. Its EDTA-free composition broadens compatibility with specialized assays. This ladder is not intended for direct quantitation or applications requiring unstained markers.
-
Angiotensin III (human, mouse): Molecular Bridge in RAAS and
2026-04-22
Explore the multifaceted role of Angiotensin III as a pivotal cardiovascular research peptide and pressor activity mediator, uncovering molecular details and new cross-domain insights that extend beyond traditional RAAS studies.
-
CX-5461: Precision RNA Polymerase I Inhibition for Advanced
2026-04-22
Explore the advanced scientific rationale and translational impact of CX-5461, a potent RNA polymerase I inhibitor, in cancer research. This article uniquely examines how mechanistic insights and protocol nuances guide selective ribosome biogenesis targeting for robust solid tumor growth inhibition.
-
MCC950 Sodium: Illuminating NLRP3 Pyroptosis in Endothelial
2026-04-21
Explore how MCC950 sodium (CRID3 sodium salt) enables advanced investigation of NLRP3-mediated pyroptosis in endothelial cell models. This article uniquely bridges inflammasome inhibition to vascular biology, offering methodological insights for inflammatory disease research.
-
COG133 Modulates miR-146a and Inflammation in Diabetic Fibro
2026-04-21
This study investigates the apolipoprotein E-mimetic peptide COG133 as a modulator of miR-146a and inflammation in diabetic dermal fibroblasts. By demonstrating COG133's ability to enhance fibroblast migration, regulate key inflammatory mediators, and inhibit bacterial growth, the paper identifies promising avenues for diabetic wound care and inflammation model research.
-
Cimetidine in Research: H2 Antagonist Applications & Protoco
2026-04-20
Cimetidine’s unique pharmacological profile as a histamine-2 receptor antagonist and partial agonist unlocks advanced applications in gastrointestinal cancer and blood-brain barrier (BBB) models. This article provides actionable experimental workflows, troubleshooting insights, and protocol parameters for leveraging Cimetidine (APExBIO) in translational research.